Canada markets open in 7 hours 39 minutes

Anatara Lifesciences Limited (ANR.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.07500.0000 (0.00%)
As of 03:24PM AEST. Market open.
Full screen
Previous Close0.0750
Open0.0750
Bid0.0730 x 6348300
Ask0.0750 x 5187600
Day's Range0.0730 - 0.0760
52 Week Range0.0470 - 0.1650
Volume103,321
Avg. Volume100,849
Market Cap5.352M
Beta (5Y Monthly)1.06
PE Ratio (TTM)N/A
EPS (TTM)-0.0320
Earnings DateAug 22, 2022 - Aug 26, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ABN Newswire

    Anatara Lifesciences Limited (ANR.AX) Annual Report to Shareholders

    2021 has been a significant year for Anatara Lifesciences Limited (ASX:ANR), as we made steps towards progressing our human health products towards clinical trials, successfully completed animal health studies and progressed licensing discussions.

  • ABN Newswire

    Anatara Lifesciences Limited (ANR.AX) Meet the CEO Investor Webinar

    Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal health in humans and animals, invites shareholders to attend a virtual group briefing with Chief Executive Officer, Steven Lydeamore, on Thursday 9 September 2021 at 11:00am AEST.

  • ABN Newswire

    Anatara Lifesciences Limited (ANR.AX) Investor Presentation

    Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals, is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today to investors.